Old Well Partners, LLC Kodiak Sciences Inc. Transaction History

Old Well Partners, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$5.04 - $9.48 $59,976 - $112,812	11,900 New	11,900 $91,000
Q1 2022 May 16, 2022	SELL	$7.09 - $89.45 $18,441 - $232,659	-2,601 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$80.85 - $128.49 $210,290 - $334,202	2,601 New	2,601 $221,000
Q2 2021 Aug 16, 2021	SELL	$77.2 - $126.54 $196,474 - $322,044	-2,545 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$60.78 - $154.03 $154,685 - $392,006	2,545 New	2,545 $374,000

39M

6.5K

5.8K

Ticker KOD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,040,200
Market Cap $455M
Description
Kodiak Sciences Inc., a clinical stage biopharmaceutical company, researches, develops, and commercializes therapeutics to treat retinal diseases. Its lead product candidate is KSI-301, an anti-vascular endothelial growth factor antibody biopolymer that is in Phase IIb/III clinical study to treat wet age-related macular degeneration (AMD), as we...

Get notified when there are updates to the investment portfolio of Old Well Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Old Well Partners, LLC with notifications on news.